We are live on ! Find out more
NCM

Nantahala Capital Management Portfolio holdings

AUM $2.72B
1-Year Est. Return 121.58%
This Fund
S&P 500
This Quarter Est. Return
+17.36%
1 Year Est. Return
+121.58%
3 Year Est. Return
+308.64%
5 Year Est. Return
+308.9%
10 Year Est. Return
+2,888.73%
AUM
$1.98B
AUM Growth
+$266M
Cap. Flow
+$123M
Cap. Flow %
6.23%
Top 10 Hldgs %
54.68%
Holding
148
New
19
Increased
38
Reduced
28
Closed
8

Top Buys

Rank Stock Value
1
FULC icon
Fulcrum Therapeutics
FULC
+$35.4M
2
TITN icon
Titan Machinery
TITN
+$24.4M
3
BKSY icon
BlackSky Technology
BKSY
+$19.4M
4
CRMT icon
America's Car Mart
CRMT
+$13.5M
5
PWSC
PowerSchool Holdings, Inc.
PWSC
+$13.2M

Top Sells

Rank Stock Value
1
CASH icon
Pathward Financial
CASH
+$17.8M
2
IMAX icon
IMAX
IMAX
+$10.2M
3
BVS icon
Bioventus
BVS
+$8.54M
4
ESTA icon
Establishment Labs
ESTA
+$6.68M
5
RDNW
RideNow Group
RDNW
+$5.58M

Sector Composition

Rank Sector Weight
1 Healthcare 41.22%
2 Consumer Discretionary 6.49%
3 Communication Services 3.21%
4 Financials 3.01%
5 Industrials 2.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PAYO icon
26
Payoneer
PAYO
$2.4B
$15.9M 0.81%
2,115,653
– –
RDNW
27
RideNow Group
RDNW
$248M
$14.7M 0.74%
3,066,537
-1,349,969
-31% -$5.58M
QURE icon
28
uniQure
QURE
$3.2B
$13.7M 0.69%
2,781,013
+130,541
+5% +$850K
PWSC
29
DELISTED
PowerSchool Holdings, Inc.
PWSC
$13.3M 0.68%
+585,000
New +$13.2M
RDVT icon
30
Red Violet
RDVT
$926M
$12.9M 0.65%
452,466
+9
+0% +$244
RSVR
31
Reservoir Media
RSVR
$656M
$12.7M 0.64%
1,560,797
+10,000
+0.6% +$76.3K
RZLT icon
32
Rezolute
RZLT
$451M
$12.5M 0.63%
2,577,121
-412,842
-14% -$1.9M
BKSY icon
33
BlackSky Technology
BKSY
$1.17B
$11.6M 0.59%
+2,450,000
New +$19.4M
ABVX
34
Abivax
ABVX
$11.1B
$11.4M 0.57%
985,634
– –
AURA icon
35
Aura Biosciences
AURA
$796M
$11.3M 0.57%
1,270,035
– –
VSTM icon
36
Verastem
VSTM
$615M
$11.2M 0.56%
3,733,333
+3,333,333
+833% +$9.04M
ELUT icon
37
Elutia
ELUT
$36M
$10.9M 0.55%
2,864,947
+1,069,250
+60% +$4.17M
ASRT
38
DELISTED
Assertio
ASRT
$10.6M 0.53%
596,556
-21,500
-3% -$426K
KRYS icon
39
PUT
Krystal Biotech
KRYS
$9.81B
$9.81M 0.5%
53,900
+50,000
+1,282% +$9.64M
OPTN
40
DELISTED
OptiNose
OPTN
$9.62M 0.49%
957,114
+62,531
+7% +$912K
EB
41
DELISTED
Eventbrite
EB
$9.18M 0.46%
3,361,200
+1,761,200
+110% +$6.7M
CDXS icon
42
Codexis
CDXS
$161M
$9.14M 0.46%
2,967,808
-661,814
-18% -$2.05M
ENVA icon
43
CALL
Enova International
ENVA
$6.29B
$9.13M 0.46%
109,000
– –
EGRX
44
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$8.79M 0.44%
2,356,536
+394,466
+20% +$1.88M
SNDX icon
45
Syndax Pharmaceuticals
SNDX
$1.82B
$8.72M 0.44%
453,232
– –
RMR icon
46
The RMR Group
RMR
$335M
$8.62M 0.44%
339,486
+38,694
+13% +$955K
COGT icon
47
Cogent Biosciences
COGT
$7.1B
$8.54M 0.43%
790,936
– –
CZR icon
48
CALL
Caesars Entertainment
CZR
$6.13B
$8.35M 0.42%
+200,000
New +$7.5M
VMD icon
49
Viemed Healthcare
VMD
$355M
$8.32M 0.42%
1,135,122
-300,000
-21% -$2.14M
CNTA
50
DELISTED
Centessa Pharmaceuticals
CNTA
$8.2M 0.41%
512,647
+62,647
+14% +$767K
1
2
3 4 5

Similar funds

TAM
Timucuan Asset Management Jacksonville, Florida $2.72B AUM 4.95% 1-Year Est. Return
XL
XN LP New York $2.72B AUM 46.67% 1-Year Est. Return
NB
Nicolet Bankshares Green Bay, Wisconsin $2.71B AUM 17.55% 1-Year Est. Return
PA
Profund Advisors Bethesda, Maryland $2.72B AUM 47.27% 1-Year Est. Return
BCM
Bowie Capital Management Richardson, Texas $2.71B AUM 5.42% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.57% 1-Year Est. Return
HCM
Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return
GC
Giverny Capital Montreal, Quebec, Canada $2.73B AUM 14.09% 1-Year Est. Return

Nantahala Capital Management's Q3 2024 Portfolio in Review

As of Q3 2024, Nantahala Capital Management held 148 positions worth $1.98B, up 16% from $1.71B the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Nantahala Capital Management deployed $123M of net new capital in Q3 2024, opening 19 new positions and adding to 38 existing holdings. Its largest new stake was Fulcrum Therapeutics: 4,777,912 shares worth $17.1M.

By sector, the portfolio is most concentrated in Healthcare at 41% of assets, up from 40% a quarter earlier, followed by Consumer Discretionary and Communication Services.

On the sell side, the largest reduction was Pathward Financial, an estimated $17.8M trimmed.

  • Nantahala Capital Management's largest Q3 2024 buy was Fulcrum Therapeutics: 4,777,912 shares worth $17.1M.
  • Nantahala Capital Management added most to America's Car Mart in Q3 2024, an estimated $13.5M increase.
  • Nantahala Capital Management's biggest Q3 2024 reduction was Pathward Financial, cutting an estimated $17.8M.
  • Nantahala Capital Management fully exited Avadel Pharmaceuticals in Q3 2024, selling an estimated $4.92M.
  • Nantahala Capital Management's ten largest holdings make up 55% of its $1.98B portfolio in Q3 2024.
  • Nantahala Capital Management opened 19 new positions and closed 8 in Q3 2024.
  • Nantahala Capital Management's portfolio value rose 16% quarter-over-quarter to $1.98B.

Based on Nantahala Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.